Zacks Investment Research upgraded shares of PHIBRO ANIMAL (PAHC) from NEUTRAL to OUTPERFORM on October 24, 2014, with a target price of $26.50.
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a broad range of products for food animals including poultry, swine, beef and dairy cattle and aquaculture. The Company offers vaccines, anti-infectives, disinfectants, mineral premixes, medicated feed additives, antimicrobials, performance chemicals, and cosmetics. Phibro Animal Health Corporation is based in Teaneck, New Jersey.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on PHIBRO ANIMAL (PAHC),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment